{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:47:15Z","timestamp":1773683235232,"version":"3.50.1"},"reference-count":42,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,2,28]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Anti-Hu paraneoplastic syndrome is a rare autoimmune complication most associated with small cell lung cancer. This case describes a man in his mid-60s with metastatic small bowel adenocarcinoma and nasopharyngeal squamous cell carcinoma who developed confusion, severe dysphagia and progressive weakness. Neurologic evaluation revealed hallucinations, disorientation and lower extremity weakness. Serum and cerebrospinal fluid were positive for anti-Hu (ANNA-1) antibodies, confirming the diagnosis. Anti-Hu disease is associated with a poor prognosis, and despite treatment with high-dose corticosteroids and intravenous immunoglobulin, his neurologic and swallowing deficits persisted. He died within 2\u2009months from progression of his cancer and paraneoplastic disease. This case highlights a rare association of anti-Hu with non-small cell nasopharyngeal and gastrointestinal cancers, expands the spectrum of underlying malignancies linked to this antibody and emphasises the importance of early recognition and timely management of paraneoplastic syndromes in patients presenting with unexplained neurological decline and severe dysphagia.<\/jats:p>","DOI":"10.1136\/bcr-2025-269641","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:50:13Z","timestamp":1773679813000},"page":"e269641","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-Hu paraneoplastic syndrome with gastrointestinal dysmotility associated with nasopharyngeal squamous cell carcinoma and small bowel adenocarcinoma"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7419-0634","authenticated-orcid":false,"given":"Jason N","family":"Chen","sequence":"first","affiliation":[{"name":"Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-8055","authenticated-orcid":false,"given":"Eric Chi Ho","family":"Leung","sequence":"additional","affiliation":[{"name":"Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Radiology, The University of Texas Health Science Center at San Antonio, San Antonio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Internal Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2026031609500620000_19.3.e269641.1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1007\/s00415-021-10577-8","article-title":"Paraneoplastic vs. non-paraneoplastic anti-Hu associated dysmotility: a case series and literature review","volume":"269","author":"Rossi","year":"2022","journal-title":"J Neurol"},{"key":"2026031609500620000_19.3.e269641.2","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1007\/s00415-024-12278-4","article-title":"Dysautonomia in anti-Hu paraneoplastic neurological syndromes","volume":"271","author":"Villagr\u00e1n-Garc\u00eda","year":"2024","journal-title":"J Neurol"},{"key":"2026031609500620000_19.3.e269641.3","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad247","article-title":"Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis","volume":"5","author":"Villagr\u00e1n-Garc\u00eda","year":"2023","journal-title":"Brain Commun"},{"key":"2026031609500620000_19.3.e269641.4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0043-1777353","article-title":"Updates in the Management of Paraneoplastic Syndrome","volume":"44","author":"Verma","year":"2024","journal-title":"Semin Neurol"},{"key":"2026031609500620000_19.3.e269641.5","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0099"},{"key":"2026031609500620000_19.3.e269641.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.024265"},{"key":"2026031609500620000_19.3.e269641.7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s10120-010-0563-2","article-title":"Paraneoplastic neurological syndrome in a patient with gastric cancer","volume":"13","author":"Murakami","year":"2010","journal-title":"Gastric Cancer"},{"key":"2026031609500620000_19.3.e269641.8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11060-009-0022-2","article-title":"Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma","volume":"97","author":"Saloustros","year":"2010","journal-title":"J Neurooncol"},{"key":"2026031609500620000_19.3.e269641.9","first-page":"414","article-title":"Paraneoplastic ataxia due to laryngeal carcinoma","volume":"49","author":"Garc\u00eda","year":"1998","journal-title":"Acta Otorrinolaringol Esp"},{"key":"2026031609500620000_19.3.e269641.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-2020-4","article-title":"Anti-Hu Antibody Associated Paraneoplastic Cerebellar Degeneration in Head and Neck Cancer","volume":"15","author":"Huemer","year":"2015","journal-title":"BMC Cancer"},{"key":"2026031609500620000_19.3.e269641.11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.2169\/internalmedicine.55.6917","article-title":"Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review","volume":"55","author":"Uneno","year":"2016","journal-title":"Intern Med"},{"key":"2026031609500620000_19.3.e269641.12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2169\/internalmedicine.51.6884","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis with esophageal small cell carcinoma","volume":"51","author":"Shirafuji","year":"2012","journal-title":"Intern Med"},{"key":"2026031609500620000_19.3.e269641.13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jocn.2017.02.015","article-title":"Anti-Hu paraneoplastic brainstem encephalitis caused by a pancreatic neuroendocrine tumor presenting with central hypoventilation","volume":"40","author":"Najjar","year":"2017","journal-title":"J Clin Neurosci"},{"key":"2026031609500620000_19.3.e269641.14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/his.14063","article-title":"The diagnosis of clinically significant oesophageal Candida infections: a reappraisal of clinicopathological findings","volume":"76","author":"Hissong","year":"2020","journal-title":"Histopathology"},{"key":"2026031609500620000_19.3.e269641.15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.158246"},{"key":"2026031609500620000_19.3.e269641.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2023935"},{"key":"2026031609500620000_19.3.e269641.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2008.02.005"},{"key":"2026031609500620000_19.3.e269641.18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology (ECronicon)"},{"key":"2026031609500620000_19.3.e269641.19","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain (Bacau)"},{"key":"2026031609500620000_19.3.e269641.20","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.479"},{"key":"2026031609500620000_19.3.e269641.21","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-12992-7","article-title":"Antibody-positive paraneoplastic neurological syndromes associated with immune checkpoint inhibitors: a systematic review","volume":"272","author":"Zhang","year":"2025","journal-title":"J Neurol"},{"key":"2026031609500620000_19.3.e269641.22","doi-asserted-by":"crossref","first-page":"117103","DOI":"10.1016\/j.jns.2020.117103","article-title":"Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study","volume":"418","author":"Oliveira","year":"2020","journal-title":"J Neurol Sci"},{"key":"2026031609500620000_19.3.e269641.23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/123.7.1481","article-title":"Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients","volume":"123 (Pt 7)","author":"Gultekin","year":"2000","journal-title":"Brain (Bacau)"},{"key":"2026031609500620000_19.3.e269641.24","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.4.388"},{"key":"2026031609500620000_19.3.e269641.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0882-0"},{"key":"2026031609500620000_19.3.e269641.26","doi-asserted-by":"publisher","DOI":"10.1586\/ern.10.134"},{"key":"2026031609500620000_19.3.e269641.27","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1468-1331.2008.02328.x","article-title":"Paraneoplastic neurological syndromes in patients with carcinoid","volume":"15","author":"Tschernatsch","year":"2008","journal-title":"Eur J Neurol"},{"key":"2026031609500620000_19.3.e269641.28","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.6.713"},{"key":"2026031609500620000_19.3.e269641.29","doi-asserted-by":"publisher","DOI":"10.1177\/039463201002300435"},{"key":"2026031609500620000_19.3.e269641.30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038148","article-title":"Anti-Hu antibody associated paraneoplastic neurological syndrome in a child with ganglioneuroblastoma: A rare case report and literature review","volume":"103","author":"Dai","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"2026031609500620000_19.3.e269641.31","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12304"},{"key":"2026031609500620000_19.3.e269641.32","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10225"},{"key":"2026031609500620000_19.3.e269641.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2007.01522.x"},{"key":"2026031609500620000_19.3.e269641.34","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/pbc.21807","article-title":"Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma","volume":"52","author":"Drukker","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"2026031609500620000_19.3.e269641.35","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010932","article-title":"Paraneoplastic limbic encephalitis associated with mixed olfactory neuroblastoma and craniopharyngioma: A case report and literature review","volume":"97","author":"Nagafuji","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2026031609500620000_19.3.e269641.36","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/jog.14031","article-title":"Case of anti-Hu antibody-mediated encephalopathy associated with ovarian cancer","volume":"45","author":"Yoshida","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"2026031609500620000_19.3.e269641.37","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030824","article-title":"Paraneoplastic Neurological Syndromes as Initial Presentation of Tumors: An Eight-Year Single-Center Experience","volume":"13","author":"Melanis","year":"2024","journal-title":"J Clin Med"},{"key":"2026031609500620000_19.3.e269641.38","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1156566","article-title":"Primary mediastinal seminoma presenting with paraneoplastic anti-Hu encephalitis: a case report and literature review","volume":"13","author":"Williams","year":"2023","journal-title":"Front Oncol"},{"key":"2026031609500620000_19.3.e269641.39","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00415-016-8090-7","article-title":"Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes","volume":"263","author":"Storstein","year":"2016","journal-title":"J Neurol"},{"key":"2026031609500620000_19.3.e269641.40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1179\/acb.2005.040","article-title":"Unclassified rhabdomyosarcoma in a patient with anti-Hu syndrome","volume":"60","author":"Schilstra","year":"2005","journal-title":"Acta Clin Belg"},{"key":"2026031609500620000_19.3.e269641.41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1468-1331.1996.tb00252.x","article-title":"Sensory neuropathy and anti\u2010Hu antibodies in a patient with seminoma","volume":"3","author":"Gabriel","year":"1996","journal-title":"Euro J of Neurology"},{"key":"2026031609500620000_19.3.e269641.42","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1212\/WNL.59.6.929","article-title":"Paraneoplastic neurological autoimmunity associated with ANNA-1 autoantibody and thymoma","volume":"59","author":"Vernino","year":"2002","journal-title":"Neurology (ECronicon)"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-269641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:50:17Z","timestamp":1773679817000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-269641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,16]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bcr-2025-269641"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-269641","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}